The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.

• Status: Unknown status
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

Perineal pain after childbirth occurs in the majority of women (with or without episiotomy). Perineal pain can become source of chronic pain in 9%-12% of the cases. Neostigmine a cholinesterase inhibitor at a dose of 500µg combined with Sufentanil or Ropivacaine (=local anaesthetic) is an analgesic. The goal of this study is to examine the effect of the use of epidural Neostigmine for perineal analgesia at the end of the labor on acute pain and on the development of chronic pain post partum.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
• Treatments: Neostigmine; Ropivacaine

Criteria

Inclusion Criteria:

• any parturient of 18-45 years

• normal pregnancy

• at full term

• having an effective epidural anesthesia during labor

Exclusion Criteria:

• multiple pregnancy

• obstetric pathology

• refusal of participation